Expression of Endothelin-1, Endothelin-Converting Enzyme, and Endothelin Receptors in Chronic Heart Failure
- 27 April 1999
- journal article
- other
- Published by Wolters Kluwer Health in Circulation
- Vol. 99 (16) , 2118-2123
- https://doi.org/10.1161/01.cir.99.16.2118
Abstract
Background —Elevated plasma levels of endothelin (ET)-1 have been reported in association with heart diseases, including heart failure. Furthermore, it has been suggested that ET-1 acts as a local autocrine/paracrine factor with biological activities such as vasoconstriction, mitogenesis, and inotropic effects on the heart. This study investigated alterations of ET-1, ET receptor, and endothelin-converting enzyme (ECE) expression in left ventricular myocardium from patients with end-stage heart failure. Methods and Results —mRNA concentrations of ET A and ET B receptors, prepro-ET-1 (ppET-1), and ECE in left ventricles from nonfailing donors hearts (NF) and from patients with end-stage chronic heart failure (NYHA functional class IV) due to dilated cardiomyopathy (DCM) were compared by use of a competitive reverse transcription–polymerase chain reaction technique. There was no significant difference in mRNA expression for ppET-1, ECE-1, and ET A receptors, whereas a significant reduction of ET B -receptor mRNA was observed in DCM hearts. 125 I-labeled ET-1 radioligand binding studies demonstrated a significant downregulation of ET B receptors, whereas ET A -receptor density was increased in membranes from DCM hearts. Phosphoramidon-sensitive ECE activity and immunodetectable amounts of ECE protein in left ventricular membrane preparations did not differ between NF and DCM hearts. Finally, immunoreactive ET-1 concentrations were increased in DCM hearts. Conclusions —The present study demonstrates changes in the ET-receptor expression pattern in favor of the ET A receptor in human end-stage heart failure. Furthermore, activation of the cardiac ET system with increased tissue ET-1 concentrations in the failing myocardium is observed. This is more likely due to decreased clearance than to increased synthesis, because ppET-1 gene expression and ECE activity are unchanged.Keywords
This publication has 14 references indexed in Scilit:
- Human endothelin-converting enzyme (ECE-1): three isoforms with distinct subcellular localizationsBiochemical Journal, 1997
- Involvement of Endothelin (ET)A and ETB Receptors in the Hypertrophic Effects of ET-1 in Rabbit Ventricular CardiomyocytesJournal of Cardiovascular Pharmacology, 1997
- Prognostic value of plasma endothelin-1 in patients with chronic heart failureEuropean Heart Journal, 1997
- Role of ETB receptors in local clearance of endothelin‐1 in rat heart: studies with the antagonists PD 155080 and BQ‐788FEBS Letters, 1996
- Organization of the Gene Encoding the Human Endothelin-converting Enzyme (ECE-1)Journal of Biological Chemistry, 1995
- Cloning and Functional Expression of Human Endothelin-Converting Enzyme cDNABiochemical and Biophysical Research Communications, 1995
- ECE-1: A membrane-bound metalloprotease that catalyzes the proteolytic activation of big endothelin-1Published by Elsevier ,1994
- Up-Regulation of ETB Receptor Subtype mRNA by Angiotensin II in Rat CardiomyocytesBiochemical and Biophysical Research Communications, 1993
- cAMP induces up-regulation of ETA receptor mRNA and increases responsiveness to endothelin-1 of rat aortic smooth muscle cells in primary cultureBiochemical and Biophysical Research Communications, 1992
- Expression of natriuretic peptide in ventricular myocardium of failing human hearts and its correlation with the severity of clinical and hemodynamic impairmentThe American Journal of Cardiology, 1990